Evidence map›Paper›PMID 27630987›Full record

ArticleFrontiers in cell and developmental biology2016

Glucose Uptake and Intracellular pH in a Mouse Model of Ductal Carcinoma In situ (DCIS) Suggests Metabolic Heterogeneity.

Rebecca C Lobo, Neil E Hubbard, Patrizia Damonte, Hidetoshi Mori, Zsófia Pénzváltó, Cindy Pham, Amanda L Koehne, Aiza C Go, Steve E Anderson, Peter M Cala and 1 more

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rebecca C LoboCenter for Comparative Medicine, University of California at Davis Davis, CA, USA.
Neil E HubbardCenter for Comparative Medicine, University of California at Davis Davis, CA, USA.
Patrizia DamonteCenter for Comparative Medicine, University of California at Davis Davis, CA, USA.
Hidetoshi MoriCenter for Comparative Medicine, University of California at Davis Davis, CA, USA.
Zsófia PénzváltóCenter for Comparative Medicine, University of California at Davis Davis, CA, USA.
Cindy PhamDepartment of Human Physiology and Membrane Biology, University of California at Davis Davis, CA, USA.
Amanda L KoehneCenter for Comparative Medicine, University of California at Davis Davis, CA, USA.
Aiza C GoCenter for Comparative Medicine, University of California at Davis Davis, CA, USA.
Steve E AndersonDepartment of Human Physiology and Membrane Biology, University of California at Davis Davis, CA, USA.
Peter M CalaDepartment of Human Physiology and Membrane Biology, University of California at Davis Davis, CA, USA.
Alexander D BorowskyCenter for Comparative Medicine, University of California at DavisDavis, CA, USA; Department of Pathology, School of Medicine, University of California at DavisSacramento, CA, USA.

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
UCD Mouse Biology Program: Pathology Resources Training and Cancer ModelingK26RR024037 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BOROWSKY, ALEXANDER D · 2007 to 2011
$717k
NCI NIH HHS P30 CA093373NCRR NIH HHS K26 RR024037
6 · The paper itself

Abstract

Mechanisms for the progression of ductal carcinoma in situ (DCIS) to invasive breast carcinoma remain unclear. Previously we showed that the transition to invasiveness in the mammary intraepithelial neoplastic outgrowth (MINO) model of DCIS does not correlate with its serial acquisition of genetic mutations. We hypothesized instead that progression to invasiveness depends on a change in the microenvironment and that precancer cells might create a more tumor-permissive microenvironment secondary to changes in glucose uptake and metabolism. Immunostaining for glucose transporter 1 (GLUT1) and the hypoxia marker carbonic anhydrase 9 (CAIX) in tumor, normal mammary gland and MINO (precancer) tissue showed differences in expression. The uptake of the fluorescent glucose analog dye, 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-D-glucose (2-NBDG), reflected differences in the cellular distributions of glucose uptake in normal mammary epithelial cells (nMEC), MINO, and Met1 cancer cells, with a broad distribution in the MINO population. The intracellular pH (pHi) measured using the fluorescent ratio dye 2',7'-bis(2-carboxyethyl)-5(6)-155 carboxyfluorescein (BCECF) revealed expected differences between normal and cancer cells (low and high, respectively), and a mixed distribution in the MINO cells, with a subset of cells in the MINO having an increased rate of acidification when proton efflux was inhibited. Invasive tumor cells had a more alkaline baseline pHi with high rates of proton production coupled with higher rates of proton export, compared with nMEC. MINO cells displayed considerable variation in baseline pHi that separated into two distinct populations: MINO high and MINO low. MINO high had a noticeably higher mean acidification rate compared with nMEC, but relatively high baseline pHi similar to tumor cells. MINO low cells also had an increased acidification rate compared with nMEC, but with a more acidic pHi similar to nMEC. These findings demonstrate that MINO is heterogeneous with respect to intracellular pH regulation which may be associated with an acidified regional microenvironment. A change in the pH of the microenvironment might contribute to a tumor-permissive or tumor-promoting progression. We are not aware of any previous work showing that a sub-population of cells in in situ precancer exhibits a higher than normal proton production and export rate.

Indexed as

ductal carcinoma in situglucose uptakeintracellular pHmouse mammary carcinoma modelproton exporttumor heterogeneitytumor microenvironment

Identifiers

PMID27630987
PMCPMC5005977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.